pharma · HIV Infections · Major Depressive Disorder · PRAX
Praxis Precision Medicines
Praxis Precision Medicines trial registry — 7 ClinicalTrials.gov studies with program phase, status, and indication context.
Boston, USA HQ
205 Employees
Public company Type
PRAX · NYSE Ticker
Company details
- Status
- Public
- HQ
- Boston, USA
- Employees
- 205
- Programs
- 7
- Drugs
- 8
- Patents
- 35
Praxis Precision Medicines clinical trials
Registry index of 7 ClinicalTrials.gov studies linked to Praxis Precision Medicines programs — each row shows trial ID, program name, phase, status, and indication.
Praxis Precision Medicines trial registry — 7 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Praxis Precision Medicines.
-
2021-02508 — Unknown
Clinical update -
PRX-P4-003, (-)-FCF — Phase 1
Clinical update -
Pneumococcal Vaccine, Polyvalent (23-valent) — Phase 1
Clinical update -
Nimotuzumab — Phase 3
Clinical update -
HIV-1 C4-V3 Polyvalent Peptide Vaccine — Phase 1
Clinical update -
10 mg PRAX-114 — Phase 2
Clinical update -
Transcutaneous Cervical Spinal Cord Stimulation — Phase 3
Clinical update -
Fused heteroaryl compounds, and methods thereof for treating diseases, disorders, and conditions relating to aberrant function of a sodium channel
Patent grant